Wendy Britten is the founder of Congenica. Congenica has raised $70M in total funding. Latest round: Series B. Backed by Parkwalk Advisors.
Wendy Britten was appointed as the Chief Financial Officer (CFO) of Congenica, a global provider of clinical genomics interpretation software, effective September 1, 2018. In this role, she is responsible for the financial aspects of the business, including business development and fundraising. Prior to Congenica, Britten worked at AstraZeneca as the head of the Group Finance Business Performance team and spent time at PricewaterhouseCoopers (PwC) in Audit and as Director of M&A in London and New York. Congenica had a Series B financing round that raised $13.5 million.
Full founder directory · Investor directory · Company funding database · Fundraising library